These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22135631)

  • 21. Causes and consequences of chronic kidney disease: implications for managed health care.
    Weiner DE
    J Manag Care Pharm; 2007 Apr; 13(3 Suppl):S1-9. PubMed ID: 17402808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep learning-based electrocardiographic screening for chronic kidney disease.
    Holmstrom L; Christensen M; Yuan N; Weston Hughes J; Theurer J; Jujjavarapu M; Fatehi P; Kwan A; Sandhu RK; Ebinger J; Cheng S; Zou J; Chugh SS; Ouyang D
    Commun Med (Lond); 2023 May; 3(1):73. PubMed ID: 37237055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and early detection of chronic kidney disease at primary healthcare.
    Nagib SN; Abdelwahab S; Amin GEE; Allam MF
    Clin Exp Hypertens; 2021 Jul; 43(5):416-418. PubMed ID: 33726610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional status, symptom burden, and predictive validity of the Pt-Global web tool/PG-SGA in CKD patients: A hospital based cross sectional study.
    Rashid I; Tiwari P; D'Cruz S; Jaswal S
    PLOS Glob Public Health; 2023; 3(1):e0001301. PubMed ID: 36962891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.
    McGill JB; Haller H; Roy-Chaudhury P; Cherrington A; Wada T; Wanner C; Ji L; Rossing P
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health.
    Saeed D; Reza T; Shahzad MW; Karim Mandokhail A; Bakht D; Qizilbash FH; Silloca-Cabana EO; Ramadhan A; Bokhari SFH
    Cureus; 2023 Dec; 15(12):e51362. PubMed ID: 38292979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapies to delay the progression of chronic kidney disease.
    Ward F; Holian J; Murray PT
    Clin Med (Lond); 2015 Dec; 15(6):550-7. PubMed ID: 26621944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Dickinson JA
    J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care.
    Li PK; Garcia-Garcia G; Lui SF; Andreoli S; Fung WW; Hradsky A; Kumaraswami L; Liakopoulos V; Rakhimova Z; Saadi G; Strani L; Ulasi I; Kalantar-Zadeh K;
    J Ren Care; 2020 Mar; 46(1):4-12. PubMed ID: 32052938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.
    Khan Z; Pandey M; Samartha RM
    Int J Health Sci (Qassim); 2016 Oct; 10(4):576-589. PubMed ID: 27833523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes.
    Obadan NO; Walker RJ; Egede LE
    J Diabetes Complications; 2017 Jun; 31(6):988-991. PubMed ID: 28363729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis.
    Fenta ET; Eshetu HB; Kebede N; Bogale EK; Zewdie A; Kassie TD; Anagaw TF; Mazengia EM; Gelaw SS
    Diabetol Metab Syndr; 2023 Nov; 15(1):245. PubMed ID: 38012781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review.
    Alkhatib L; Velez Diaz LA; Varma S; Chowdhary A; Bapat P; Pan H; Kukreja G; Palabindela P; Selvam SA; Kalra K
    Cureus; 2023 Feb; 15(2):e34572. PubMed ID: 36874334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
    George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
    BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic burden of chronic kidney disease.
    Khan S; Amedia CA
    J Eval Clin Pract; 2008 Jun; 14(3):422-34. PubMed ID: 18373575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
    Levey AS; Atkins R; Coresh J; Cohen EP; Collins AJ; Eckardt KU; Nahas ME; Jaber BL; Jadoul M; Levin A; Powe NR; Rossert J; Wheeler DC; Lameire N; Eknoyan G
    Kidney Int; 2007 Aug; 72(3):247-59. PubMed ID: 17568785
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.